Medical economics and the assessment of value in cardiovascular medicine: Part II

被引:39
作者
Mark, DB
Hlatky, MA
机构
[1] Duke Univ, Clin Res Inst, Outcomes Res & Assessment Grp, Durham, NC 27715 USA
[2] Stanford Univ, Div Hlth Res & Policy, Stanford, CA 94305 USA
关键词
cost-benefit analysis; cardiovascular disease; financing;
D O I
10.1161/01.CIR.0000021408.40925.63
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:626 / 630
页数:5
相关论文
共 27 条
[1]  
Alderman EL, 2000, J AM COLL CARDIOL, V35, P1122
[2]  
American Heart Association, 2001, 2001 HEART STROK STA
[3]  
BUTCHER HC, 2000, BMJ-BRIT MED J, V321, P73
[4]   The west of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin [J].
Caro, J ;
Klittich, W ;
McGuire, A ;
Ford, J ;
Norrie, J ;
Pettitt, D ;
McMurray, J ;
Shepherd, J .
BRITISH MEDICAL JOURNAL, 1997, 315 (7122) :1577-1582
[5]  
Chamberlain DA, 1997, LANCET, V350, P461
[6]   Cost effectiveness of carvedilol for heart failure [J].
Delea, TE ;
Vera-Llonch, M ;
Richner, RE ;
Fowler, MB ;
Oster, G .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (06) :890-896
[7]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[8]  
Glick H, 1995, J Card Fail, V1, P371, DOI 10.1016/S1071-9164(05)80006-5
[9]   Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels -: Subgroup analyses in the cholesterol and recurrent events (CARE) trial [J].
Goldberg, RB ;
Mellies, MJ ;
Sacks, FM ;
Moyé, LA ;
Howard, BV ;
Howard, WJ ;
Davis, BR ;
Cole, TG ;
Pfeffer, MA ;
Braunwald, E .
CIRCULATION, 1998, 98 (23) :2513-2519
[10]  
HARTIGAN P, 1998, AM COLL CARD 47 ANN